Shuttle Pharmaceuticals Holdings (SHPH) Profit After Tax (2021 - 2026)

Shuttle Pharmaceuticals Holdings has reported Profit After Tax for 6 years, with the latest figure at -$2.2 million in Q1 2026.

• On a quarterly basis, Profit After Tax rose 27.94% year-over-year to -$2.2 million in Q1 2026; TTM through Mar 2026 was -$10.9 million, a 3.84% decrease from a year earlier, with the FY2025 full-year figure at -$11.7 million, down 28.18% from the prior year.
• Profit After Tax was -$2.2 million for Q1 2026 at Shuttle Pharmaceuticals Holdings, up from -$2.6 million in the prior quarter.
• The five-year high for Profit After Tax was -$597275.0 in Q2 2022, with the low at -$3.8 million in Q3 2024.
• Average Profit After Tax over 5 years is -$1.9 million, with a median of -$1.8 million recorded in 2023.
• The sharpest annual moves came in 2022 and 2025: Profit After Tax plunged 360.19% in 2022, then surged 37.97% in 2025.
• Over 5 years, Profit After Tax stood at -$750909.0 in 2022, then plunged by 118.47% to -$1.6 million in 2023, then grew by 2.56% to -$1.6 million in 2024, then plunged by 63.59% to -$2.6 million in 2025, then advanced by 15.87% to -$2.2 million in 2026.
• The last three Profit After Tax figures came in at -$2.2 million (Q1 2026), -$2.6 million (Q4 2025), and -$2.3 million (Q3 2025), per Business Quant data.